Apotex Loses Battle With Daiichi Over Ear-Drop Patent

Law360, New York (August 3, 2006, 12:00 AM EDT) -- A New Jersey district court has rejected Apotex Inc.’s generic challenge to Daiichi Sankyo Co.’s Floxin Otic, handing the Japanese pharmaceutical giant a crucial victory in the long-simmering patent brawl over the groundbreaking ear-drop medicine.

Judge William G. Bassler of the U.S. District Court for the District of New Jersey granted Daiichi’s request for summary judgment, ruling that its method-of-treatment patent is valid and enforceable and was infringed by the Canadian manufacturer's generic product.

Daiichi confirmed the news on Thursday, revealing in a filing with the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.